These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1676 related items for PubMed ID: 35256934

  • 1. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J.
    Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
    [Abstract] [Full Text] [Related]

  • 2. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y, Hunter C, Roccio F, Zagkou S, Dupont N, Primard C, Proikas-Cezanne T, Reggiori F.
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [Abstract] [Full Text] [Related]

  • 3. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS, Harrison DJ, Kisielewski D, Cassidy DM, McNeilly AD, Gallagher JR, Walsh SV, Honda T, McCrimmon RJ, Dinkova-Kostova AT, Ashford MLJ, Dillon JF, Hayes JD.
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [Abstract] [Full Text] [Related]

  • 4. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT, Yudell BE, Loor JJ.
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [Abstract] [Full Text] [Related]

  • 5. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G, Bellanti F, Vendemiale G.
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [Abstract] [Full Text] [Related]

  • 6. MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers.
    Pinweha P, Rattanapornsompong K, Charoensawan V, Jitrapakdee S.
    Comput Struct Biotechnol J; 2016 Dec; 14():223-33. PubMed ID: 27358718
    [Abstract] [Full Text] [Related]

  • 7. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS, Song JW, Park JH, Lim BK, Moon OS, Son HY, Lee JH, Gao B, Won YS, Kwon HJ.
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [Abstract] [Full Text] [Related]

  • 8. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M, Ma LJ, Yang Y, Xiao Z, Wan JB.
    Crit Rev Food Sci Nutr; 2019 Sep; 59(sup1):S116-S129. PubMed ID: 30580553
    [Abstract] [Full Text] [Related]

  • 9. Lipid alterations in chronic liver disease and liver cancer.
    Paul B, Lewinska M, Andersen JB.
    JHEP Rep; 2022 Jun; 4(6):100479. PubMed ID: 35469167
    [Abstract] [Full Text] [Related]

  • 10. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
    Shearn CT, Smathers RL, Jiang H, Orlicky DJ, Maclean KN, Petersen DR.
    J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
    [Abstract] [Full Text] [Related]

  • 11. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes.
    Ghashghaeinia M, Köberle M, Mrowietz U, Bernhardt I.
    Cell Cycle; 2019 Jun; 18(12):1316-1334. PubMed ID: 31154896
    [Abstract] [Full Text] [Related]

  • 12. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 13. Solute carrier transporters: the metabolic gatekeepers of immune cells.
    Song W, Li D, Tao L, Luo Q, Chen L.
    Acta Pharm Sin B; 2020 Jan; 10(1):61-78. PubMed ID: 31993307
    [Abstract] [Full Text] [Related]

  • 14. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M.
    Int J Cardiol; 2013 Oct 09; 168(4):3160-72. PubMed ID: 23932046
    [Abstract] [Full Text] [Related]

  • 15. Effect of Korean Red Ginseng on metabolic syndrome.
    Yoon SJ, Kim SK, Lee NY, Choi YR, Kim HS, Gupta H, Youn GS, Sung H, Shin MJ, Suk KT.
    J Ginseng Res; 2021 May 09; 45(3):380-389. PubMed ID: 34025131
    [Abstract] [Full Text] [Related]

  • 16. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
    Zheng ZG, Zhu ST, Cheng HM, Zhang X, Cheng G, Thu PM, Wang SP, Li HJ, Ding M, Qiang L, Chen XW, Zhong Q, Li P, Xu X.
    Autophagy; 2021 Jul 09; 17(7):1592-1613. PubMed ID: 32432943
    [Abstract] [Full Text] [Related]

  • 17. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 09; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 18. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X, Liu Q, Li Y, Tang Q, Wu T, Chen L, Pu S, Zhao Y, Zhang G, Huang C, Zhang J, Zhang Z, Huang Y, Zou M, Shi X, Jiang W, Wang R, He J.
    Adipocyte; 2020 Dec 09; 9(1):484-494. PubMed ID: 32835596
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
    Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E.
    BBA Clin; 2015 Jun 09; 3():168-74. PubMed ID: 26674248
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation.
    Balakrishnan K.
    Med Oncol; 2022 Oct 08; 39(12):247. PubMed ID: 36209296
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 84.